Amedisys to Present at the 34th Annual J.P. Morgan Healthcare Conference
January 07 2016 - 12:00PM
Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health
and hospice care companies, today announced that Paul B. Kusserow,
President and Chief Executive Officer will present at the 34th
Annual J.P. Morgan Healthcare Conference in San Francisco, CA on
Wednesday, January 13, 2016.
The presentation will begin at 5:00 p.m. Pacific Time. To
access a live webcast of the Amedisys presentation, please log on
through our website at http://investors.amedisys.com.
About Amedisys: Amedisys, Inc. (NASDAQ:AMED) is
a leading health care at home company delivering personalized home
health and hospice care to more than 360,000 patients each year.
Amedisys is focused on delivering the care that is best for our
patients, whether that is home-based recovery and rehabilitation
after an operation or injury, care focused on empowering them to
manage a chronic disease, palliative care for those with a terminal
illness, or hospice care at the end of life. The Company's
state-of-the-art advanced chronic care management programs and
leading-edge technology enables it to deliver quality care based
upon the latest evidence-based best practices. Amedisys is a
recognized innovator, being one of the first in the industry to
equip its clinicians with point-of-care laptop technology and
referring physicians with an internet portal that enables real-time
coordination of patient care seamlessly. Amedisys also has the
industry's first-ever nationwide Care Transitions program, designed
to reduce unnecessary hospital readmissions through patient and
caregiver health coaching and care coordination, which starts in
the hospital and continues throughout completion of the patient's
home health plan of care. For more information about the Company,
please visit: http://www.amedisys.com.
Our company website address is http://www.amedisys.com. We
use our website as a channel of distribution for important company
information. Important information, including press releases,
analyst presentations and financial information regarding the
Company is routinely posted on and accessible on the "Investor
Relations" subpage of our website, which is accessible by clicking
on the tab labeled "Investors" on our website home page. We will
also use our website to expedite public access to time-critical
information regarding the Company in advance of or in lieu of
distributing a press release or a filing with the Securities and
Exchange Commission ("SEC") disclosing the same information. In
addition, we make available on the Investor Relations subpage of
our website (under the link "SEC filings") free of charge our
annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, ownership reports on Forms 3, 4 and 5
and any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of
our Certificate of Incorporation and Bylaws, our Code of Ethical
Business Conduct and the charters for the Audit, Compensation and
Nominating and Governance Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
Contact:
Amedisys, Inc.
David Castille
Managing Director, Finance
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024